The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy

scientific article published on 01 August 1974

The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID4152327

P2093author name stringGobel FL
Goodwin JF
Hardarson T
Oakley CM
Shah PM
Adelman AG
Wigle ED
Burchell HB
Curiel R
De La Calzada C
P433issue2
P921main subjecthypertrophic obstructive cardiomyopathyQ55065467
P304page(s)suppl II:179-95
P577publication date1974-08-01
P1433published inCirculation ResearchQ2599020
P1476titleThe natural (and unnatural) history of hypertrophic obstructive cardiomyopathy
P478volume35

Reverse relations

cites work (P2860)
Q67014753Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis
Q35770817Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
Q42339402Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment
Q68991974Hypertrophic cardiomyopathy, ten years' experience
Q36492134Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy
Q39898213Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imaging
Q58565838Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review
Q33174589Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy
Q33171846Long-term medical management of hypertrophic obstructive cardiomyopathy
Q60921259Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand
Q33145751Natural history of hypertrophic cardiomyopathy
Q42680372Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study
Q40086997The frontiers of cardiomyopathy
Q31934960The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era.
Q47613563Women with hypertrophic cardiomyopathy have worse survival.

Search more.